Treatment with Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, Decreases Serum Cholesterol in Patients with Lung Cancer
2016 ◽
Vol 25
(4)
◽
pp. 233-239
◽
2009 ◽
Vol 16
(1)
◽
pp. 174-183
◽
2019 ◽
Vol 62
(22)
◽
pp. 10108-10123
◽
2006 ◽
Vol 1
(7)
◽
pp. 740-743
◽
2007 ◽
Vol 67
(13)
◽
pp. 6253-6262
◽
2009 ◽
Vol 1
(3)
◽
pp. 137-144
◽